Search research articles

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Liver Tissueoid on-a-Chip Modeling Liver Regeneration and Allograft Rejection.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

PayloadGenX, a multi-stage hybrid virtual screening approach for payload design: A microtubule inhibitor case study.

Computational biology and chemistry·2025

Same author

Revolutionizing Biomedical Research: Unveiling the Power of Microphysiological Systems with Advanced Assays, Integrated Sensor Technologies, and Real-Time Monitoring.

ACS omega·2025

Same author

Unraveling new avenues in pancreatic cancer treatment: A comprehensive exploration of drug repurposing using transcriptomic data.

Computers in biology and medicine·2024

Same author

Granular Porous Nanofibrous Microspheres Enhance Cellular Infiltration for Diabetic Wound Healing.

ACS nano·2024

Same author

Integrated ML-Based Strategy Identifies Drug Repurposing for Idiopathic Pulmonary Fibrosis.

ACS omega·2024

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Purification of Transcripts and Metabolites from Drosophila Heads

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

Integrating Transcriptomic and Structural Insights: Revealing Drug Repurposing Opportunities for Sporadic ALS.

Naina Sunildutt¹, Faheem Ahmed¹, Abdul Rahim Chethikkattuveli Salih^1,2

¹Department of Mechatronics Engineering, Jeju National University, Jeju63243, Republic of Korea.

|January 29, 2024

Summary

This study repurposed existing drugs for amyotrophic lateral sclerosis (ALS) treatment. Lestaurtinib showed promise as a broad-spectrum agent, and NOS3 was identified as a key interacting gene for potential ALS therapies.

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

Related Experiment Videos

Last Updated: Jun 23, 2026

Purification of Transcripts and Metabolites from Drosophila Heads

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

Area of Science:

Neuroscience
Pharmacology
Bioinformatics

Background:

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no effective treatments.
Current ALS management faces significant challenges due to disease progression and limited therapeutic options.

Purpose of the Study:

To identify potential drug candidates for repurposing in sporadic amyotrophic lateral sclerosis (ALS) treatment.
To systematically screen existing drugs for efficacy against ALS using computational methods.

Main Methods:

Bioinformatic analysis of sporadic ALS-related genes from the GEO database.
Pathway analysis using DAVID and drug candidate identification via Clue Connectivity Map.
Molecular docking simulations using AutoDock Vina to assess drug-target binding affinity.

Main Results:

Nine potential drug candidates were identified, including Lestaurtinib, which showed high binding affinity to multiple proteins.
NOS3 was identified as a gene interacting with all screened drugs, suggesting its role in therapeutic mechanisms.
The study provides a framework for drug repurposing in neurodegenerative diseases.

Conclusions:

Drug repurposing offers a promising strategy for discovering novel amyotrophic lateral sclerosis (ALS) therapies.
Lestaurtinib and other identified compounds warrant further investigation for sporadic ALS treatment.
Understanding gene interactions like NOS3 is crucial for developing targeted ALS therapies.